« Previous
Next »
Titles
- Management of patients with opioid dependence: a review of clinical, delivery system, and policy options1
- Measuring up: access to care in Medi-Cal compared to other types of health insurance (2018)1
- Measuring up?: end-of-life cancer care in California1
- Medi-Cal behavioral health services: demand exceeds supply despite expansions1
- Medi-Cal facts and figures: essential source of coverage for millions1
- Medicare and Medicaid: CMS needs to fully align its antifraud efforts with the fraud risk framework : report to Congressional addressees1
- Medicare and beneficiaries pay more for preadmission services at affiliated hospitals than at wholly owned settings1
- Medicare and home health: taking stock in the COVID-19 era1
- Medicare cognitive assessments: utilization tripled between 2018 and 2022, but challenges remain : report to congressional committees1
- Medicare lacks consistent oversight of cybersecurity for networked medical devices in hospitals1
- Medicare program shared savings accountable care organizations have shown potential for reducing spending and improving quality1
- Medicare telehealth services during the first year of the pandemic: program integrity risks1
- Medicare's mental health coverage: how COVID-19 highlights gaps and opportunities for improvement1
- Medicare's new adventure: the Part D drug benefit1
- Medicare's oversight of ambulatory surgery centers: a data brief1
- Medicare: CMS Fraud Prevention System uses claims analysis to address fraud : report to Congressional requesters1
- Medicare: CMS should provide beneficiaries more information about substance use disorder coverage : report to Congressional committees1
- Medicare: Performance-based and geographic adjustments to physician payments : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives1
- Medicare: actions needed to better manage fraud risks : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives1
- Most hospitals obtain compounded drugs from outsourcing facilities, which must meet FDA quality standards1